Rankings
▼
Calendar
ACAD FY 2013 Earnings — ACADIA Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
ACAD
ACADIA Pharmaceuticals Inc.
$4B
FY 2013 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1M
-76.7% YoY
Gross Profit
-$26M
-2233.8% margin
Operating Income
-$38M
-3344.7% margin
Net Income
-$38M
-3314.2% margin
EPS (Diluted)
$-0.44
Cash Flow
Operating Cash Flow
-$32M
Free Cash Flow
-$32M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$189M
Total Liabilities
$7M
Stockholders' Equity
$182M
Cash & Equivalents
$12M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1M
$5M
-76.7%
Gross Profit
-$26M
-$14M
-84.2%
Operating Income
-$38M
-$21M
-83.4%
Net Income
-$38M
-$21M
-82.0%
← FY 2012
All Quarters
FY 2014 →